The cervical cancer (CC) market was valued at $607 million in the 8 major markets (8MM) in 2020. The market is projected to grow at a CAGR of more than 22% during the forecast period.

The cervical cancer market report provides an overview of the risk factors, comorbidities, and global and historical trends for cervical cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Urban China). It includes a 10-year epidemiological forecast for diagnosed incident cases of CC. The diagnosed incident cases of CC are further segmented by age (18–29 years, 30–39 years, 40–49 years, 50–59 years, 60–69 years, 70–79 years, and 80 years and older) in these markets.